Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × canakinumab × Clear all

Phase

Status

Recruiting 5 Active not recruiting 3 Terminated 1 Completed 1

Sponsor Class

INDUSTRY 4 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Cyclophosphamide 220 Radiotherapy 196 Carboplatin 166 Cisplatin 162 Gemcitabine 161 Bevacizumab 145 Docetaxel 143 Paclitaxel 130 Rituximab 127 Capecitabine 127 pembrolizumab 121 Oxaliplatin 112 Nivolumab 110 Dexamethasone 110 Fluorouracil 105 fludarabine 91 Doxorubicin 91 Irinotecan 89 Radiosurgery 88 Etoposide 88 fludarabine phosphate 85 Lenalidomide 85 Cytarabine 85 Filgrastim 84 Leucovorin 82 Radiation 81 Magnetic Resonance Spectroscopy 80 Bortezomib 77 Temozolomide 72 Pemetrexed 71

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05725343 2023-02-13

CANAL

Mario Negri Institute for Pharmacological Research

Phase 3 Terminated

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡